GlassScriptPhysician profile
Sheila Vasan
NPI 1487846416
$41,155.65
in general payments reported to CMS, 2019-2025
91 companies · $6,061 in 2025
The $6,061 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,667 · 2020: $7,462 · 2021: $4,701 · 2022: $5,118 · 2023: $5,543 · 2024: $6,603 · 2025: $6,061.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Long Term Medical Supply Or Device Loan: $1,515 · Education: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,111.16 |
| Long Term Medical Supply Or Device Loan | $1,514.83 |
| Education | $581.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,891.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,314.74 | 2019-2025 | Enhertu, Lynparza, Tagrisso |
| Karyopharm Therapeutics INC. | $2,219.22 | 2020-2025 | Xpovio |
| E.R. Squibb & Sons, L.L.C. | $2,157.62 | 2019-2025 | Opdivo, Opdualag, Abecma |
| Incyte Corporation | $2,044.30 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Pfizer INC. | $1,861.66 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,794.28 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Puma Biotechnology, INC. | $1,493.88 | 2019-2025 | Nerlynx |
| Janssen Biotech, INC. | $1,134.00 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Celgene Corporation | $1,124.20 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Seagen INC. | $1,062.20 | 2019-2025 | Adcetris, Padcev, Tukysa |
| Genzyme Corporation | $1,005.87 | 2019-2025 | |
| Genentech USA, INC. | $994.16 | 2019-2025 | Venclexta, Phesgo, Tecentriq Hybreza |
| Astellas Pharma US INC | $958.20 | 2019-2025 | Xospata, Vyloy, Xtandi |
| Eisai INC. | $957.55 | 2019-2025 |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $926.53 | 2019-2023 | Xgeva, Vectibix, Nplate |
| Takeda Pharmaceuticals U.S.A., INC. | $893.17 | 2019-2025 | Fruzaqla, Iclusig, Alunbrig |
| Exelixis INC. | $809.86 | 2019-2025 | Cabometyx |
| Glaxosmithkline, LLC. | $704.56 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Daiichi Sankyo INC. | $659.12 | 2019-2025 | Enhertu, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $652.86 | 2019-2025 | |
| Lilly USA, LLC | $617.84 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Ipsen Biopharmaceuticals, INC | $602.01 | 2019-2025 | Onivyde, Tazverik |
| Alexion Pharmaceuticals, INC. | $597.35 | 2019-2024 | Ultomiris |
| Gilead Sciences, INC. | $534.54 | 2019-2025 | Trodelvy |
| Abbvie INC. | $517.08 | 2019-2025 | Venclexta |
| Emd Serono, INC. | $421.96 | 2019-2025 | Bavencio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $416.79 | 2019-2025 | Gilotrif |
| Taiho Oncology, INC. | $351.60 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $333.43 | 2019-2023 | Imbruvica |
| Tersera Therapeutics LLC | $313.67 | 2019-2024 | Zoladex |
| Pharmaessentia USA Corporation | $305.98 | 2023-2025 | Besremi |
| Rigel Pharmaceuticals, INC. | $299.42 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Genmab U.S., INC. | $248.81 | 2023-2025 | Epkinly |
| Beigene USA, INC. | $240.31 | 2020-2023 | Brukinsa |
| Caris Mpi, INC. | $239.06 | 2025 | Mi Cancer Seek |
| Clovis Oncology, INC. | $233.84 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $227.04 | 2022-2025 | Libtayo |
| Stemline Therapeutics INC. | $216.76 | 2024-2025 | Orserdu, Elzonris |
| Array Biopharma INC | $203.81 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Sun Pharmaceutical Industries INC. | $201.72 | 2020-2025 | Yonsa |
| Jazz Pharmaceuticals INC. | $190.54 | 2020-2025 | |
| Blueprint Medicines Corporation | $181.46 | 2023-2025 | Ayvakit |
| Teva Pharmaceuticals USA, INC. | $180.93 | 2019-2024 | Truxima |
| Foundation Medicine, INC. | $170.89 | 2020-2023 | Foundationone Cdx |
| Tolmar Pharmaceuticals, INC. | $155.84 | 2020-2022 | |
| Janssen Scientific Affairs, LLC | $144.81 | 2023 | Erleada |
| Sobi, INC | $142.85 | 2022-2025 | |
| Kyowa Kirin, INC. | $125.79 | 2019-2020 | |
| Kite Pharma, INC. | $121.11 | 2021-2024 | Yescarta |
| Dova Pharmaceuticals | $120.29 | 2020-2021 | |
| Deciphera Pharmaceuticals INC. | $99.50 | 2023-2025 | Qinlock, Tgct, Romvimza |
| Morphosys, US INC. | $98.26 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $97.21 | 2021-2024 | Monoferric, Cosela |
| Agios Pharmaceuticals, INC. | $95.66 | 2023-2025 | Pyrukynd |
| Eusa Pharma (US) LLC | $84.80 | 2021-2022 | |
| Tesaro, INC. | $84.55 | 2019 | |
| Myovant Sciences INC. | $70.10 | 2021-2022 | |
| Mirati Therapeutics, INC. | $69.51 | 2023-2024 | Krazati |
| Heron Therapeutics, INC. | $65.26 | 2019-2022 | |
| Adc Therapeutics America, INC. | $64.83 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $61.25 | 2019-2020 | |
| Fennec Pharmaceuticals, INC. | $58.38 | 2024-2025 | Fyarro, Pedmark |
| Geron Corporation | $56.43 | 2025 | Rytelo |
| Immunogen, INC. | $56.39 | 2023-2024 | Elahere, Elahere |
| Intuitive Surgical, INC. | $56.38 | 2024 | |
| Iovance Biotherapeutics, INC. | $56.20 | 2025 | Amtagvi |
| Beone Medicines USA, INC. | $55.50 | 2025 | Tevimbra |
| Apellis Pharmaceuticals, INC. | $46.33 | 2023 | Empaveli |
| Novocure INC. | $42.52 | 2025 | Optune Lua (Novottf-200t) |
| Spectrum Pharmaceuticals INC. | $42.33 | 2019-2023 | Rolvedon |
| Global Blood Therapeutics, INC. | $40.78 | 2022 | |
| Azurity Pharmaceuticals, INC. | $35.61 | 2025 | Danziten, Vivimusta |
| Sirtex Medical INC | $34.88 | 2020 | |
| Secura Bio, INC. | $31.97 | 2020 | |
| Immunocore Limited | $31.90 | 2024 | Kimmtrak |
| Acrotech Biopharma INC. | $27.36 | 2025 | Beleodaq |
| Springworks Therapeutics, INC. | $25.51 | 2024 | Ogsiveo |
| Servier Pharmaceuticals LLC | $24.25 | 2025 | |
| Sanofi-Aventis U.S. LLC | $23.23 | 2019 | |
| Sumitomo Pharma America, INC. | $22.60 | 2023 | Orgovyx |
| Mylan Institutional INC. | $21.46 | 2019 | |
| G1 Therapeutics, INC. | $21.00 | 2023 | Cosela |
| Tolmar, INC. | $20.77 | 2023 | |
| Progenics Pharmaceuticals, INC. | $19.68 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $18.33 | 2019 | |
| Recordati_rare_diseases_inc. | $16.88 | 2024 | Sylvant |
| Shire North American Group INC | $16.18 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $16.05 | 2024 | Sancuso |
| Ge Healthcare | $14.74 | 2021 | |
| Advanced Accelerator Applications | $14.53 | 2020 |
Drugs and devices associated with these payments
Kisqali $1,517Keytruda $924Enhertu $911Jakafi $692Lenvima $562Lynparza $558Reblozyl $525Opdivo $461Adcetris $357Tecvayli $321Verzenio $308Xpovio $306Besremi $306Elrexfio $285Epkinly $275Erleada $262Welireg $253Retevmo $252Jaypirca $252Tagrisso $249Onivyde $239Mi Cancer Seek $239Darzalex $237Calquence $223Ayvakit $223Cabometyx $215Monjuvi $214Talvey $210Lonsurf $205Inqovi $205Rybrevant $204Imfinzi $204Carvykti $202Trodelvy $197Imbruvica $197Libtayo $193Fruzaqla $183Scemblix $181Tivdak $170Xospata $168Iclusig $164Zejula $163Venclexta $162Vitrakvi $160Stivarga $160Pemazyre $160Elahere $157Orserdu $154Xtandi $154Braftovi $153Opdualag $147Bosulif $145Zoladex $140Sarclisa $132Padcev $129Ultomiris $121Lorbrena $115Tukysa $110Mektovi $110Qinlock $99.50Jemperli $98.28Tabrecta $97.54Pyrukynd $95.66Nubeqa $94.73Fabhalta $94.29Vyloy $90.78Tavalisse $87.14Gilotrif $86.93Ojjaara $84.17Nerlynx $79.75Yonsa $78.57Ibrance $77.88Xalkori $77.42Tazverik $72.54Phesgo $72.08Inlyta $71.28Talzenna $71.09Krazati $69.51Orgovyx $67.81Brukinsa $66.59Zynlonta $64.83Keytruda Qlex $62.86Elzonris $62.58Zepzelca $61.25Pluvicto $57.06Rytelo $56.43Da Vinci Surgical System $56.38Amtagvi $56.20Rezlidhia $55.99Tevimbra $55.50Zynyz $54.54Odomzo $52.07Vectibix $51.20Nplate $51.20Xgeva $51.20Kyprolis $48.52Alunbrig $47.59Tecentriq $46.96Itovebi $46.96Tecentriq Hybreza $46.96
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Vasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.